Ribosomal RNA degradation induced by the bacterial RNA polymerase inhibitor rifampicin.

RNA
L. HamoucheAgamemnon J. Carpousis

Abstract

Rifampicin, a broad-spectrum antibiotic, inhibits bacterial RNA polymerase. Here we show that rifampicin treatment of Escherichia coli results in a 50% decrease in cell size due to a terminal cell division. This decrease is a consequence of inhibition of transcription as evidenced by an isogenic rifampicin-resistant strain. There is also a 50% decrease in total RNA due mostly to a 90% decrease in 23S and 16S rRNA levels. Control experiments showed this decrease is not an artifact of our RNA purification protocol and therefore due to degradation in vivo. Since chromosome replication continues after rifampicin treatment, ribonucleotides from rRNA degradation could be recycled for DNA synthesis. Rifampicin-induced rRNA degradation occurs under different growth conditions and in different strain backgrounds. However, rRNA degradation is never complete thus permitting the re-initiation of growth after removal of rifampicin. The orderly shutdown of growth under conditions where the induction of stress genes is blocked by rifampicin is noteworthy. Inhibition of protein synthesis by chloramphenicol resulted in a partial decrease in 23S and 16S rRNA levels whereas kasugamycin treatment had no effect. Analysis of temperature-sensitive mu...Continue Reading

References

Jan 1, 1991·Proceedings of the National Academy of Sciences of the United States of America·P Babitzke, S R Kushner
Sep 1, 1974·Journal of Bacteriology·F C NeidhardtD F Smith
Mar 24, 1999·Trends in Genetics : TIG·A J CarpousisL C Raynal
May 14, 2003·Proceedings of the National Academy of Sciences of the United States of America·Zhuan-Fen Cheng, Murray P Deutscher
Feb 26, 2004·Proceedings of the National Academy of Sciences of the United States of America·Jonathan A BernsteinSue Lin-Chao
Jan 25, 2005·Molecular Cell·Zhuan-Fen Cheng, Murray P Deutscher
Feb 3, 2006·Nucleic Acids Research·Murray P Deutscher
Oct 16, 2007·BioTechniques·Tony J Collins
Feb 14, 2009·Progress in Molecular Biology and Translational Science·Agamemnon J CarpousisKenneth J McDowall
Feb 14, 2009·Progress in Molecular Biology and Translational Science·Murray P Deutscher
Mar 28, 2009·RNA·Michael A ZundelMurray P Deutscher
Nov 12, 2010·Cold Spring Harbor Perspectives in Biology·Peter B Moore, Thomas A Steitz
Jun 7, 2011·Annual Review of Microbiology·Aurelia BattestiSusan Gottesman
Aug 2, 2012·Revue Scientifique Et Technique·T Lambert
Aug 30, 2012·Nature Methods·Caroline A SchneiderKevin W Eliceiri
Dec 18, 2012·Nature Reviews. Microbiology·George A Mackie
Mar 9, 2013·Cold Spring Harbor Perspectives in Biology·Kirsten Skarstad, Tsutomu Katayama
Oct 9, 2014·Annual Review of Genetics·Monica P HuiJoel G Belasco
Dec 8, 2014·Journal of Biotechnology·Pietro AlifanoAdelfia Talà
May 13, 2015·Molecular Systems Biology·Huiyi ChenXiaoliang Sunney Xie
May 21, 2016·ELife·Jeffrey R MoffittXiaowei Zhuang
Jun 4, 2016·Antibiotics·Christian MüllerIsabella Moll
Dec 3, 2016·Nucleic Acids Research·Sine Lo SvenningsenMichael A Sørensen
Jan 7, 2017·Molecular Cell·Joel G Belasco
Apr 5, 2017·Annual Review of Biophysics·Zhichao Miao, Eric Westhof
Mar 13, 2018·Environmental Microbiology·Jun-Seob KimThomas K Wood
Apr 19, 2018·PLoS Genetics·Daniel Dar, Rotem Sorek
Dec 7, 2018·Methods in Enzymology·Sandrine LaguerreLaurence Girbal
Jan 10, 2019·Proceedings of the National Academy of Sciences of the United States of America·Satoshi Kimura, Matthew K Waldor

❮ Previous
Next ❯

Citations

Jul 25, 2021·Biotechnology Advances·Charlotte RouxLaurence Girbal

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.